Linker-Israeli M, Gray J D, Quismorio F P, Horwitz D A
Department of Medicine, University of Southern California, School of Medicine, Los Angeles 910033.
Clin Exp Immunol. 1988 Aug;73(2):236-41.
IL-2 production by peripheral blood mononuclear cells (PBM) is decreased in patients with systemic lupus erythematosus (SLE). This defect can be reversed by the removal of CD8+ lymphocytes. The purpose of these studies was to determine whether the CD8+ IL-2 suppressor cells comprise a specific subset or whether all CD8+ cells have this activity. Lymphocyte subsets were identified and separated by two-colour flow cytometry prior to a 48 h mitogen stimulation. The CD8+ cells that suppressed IL-2 production co-expressed HLA DR and were radiosensitive. Other markers co-expressed by CD8+ cells which are found on suppressor cells such as Leu 15 (CD11), Leu 11 (CD16), and Leu 7 were also found on the CD8+ IL-2 suppressor cell population in SLE. In healthy subjects, removal of CD16+, but not of CD8+ cells markedly elevated the production of IL-2. The CD8- CD16+ non-T cell subset suppressed IL-2 production by normal and SLE PBM in autologous and allogeneic combinations. This subset may be a human equivalent of the murine natural suppressor cells. These results demonstrate that the cells that suppress IL-2 production in SLE are heterogeneous, and suggest that they belong to more than one lineage.
系统性红斑狼疮(SLE)患者外周血单个核细胞(PBM)产生白细胞介素-2(IL-2)的能力下降。去除CD8⁺淋巴细胞可逆转这一缺陷。这些研究的目的是确定CD8⁺IL-2抑制细胞是构成一个特定亚群,还是所有CD8⁺细胞都具有这种活性。在进行48小时有丝分裂原刺激之前,通过双色流式细胞术鉴定并分离淋巴细胞亚群。抑制IL-2产生的CD8⁺细胞共表达HLA-DR且对辐射敏感。在SLE患者的CD8⁺IL-2抑制细胞群体中也发现了抑制细胞上存在的CD8⁺细胞共表达的其他标志物,如Leu 15(CD11)、Leu 11(CD16)和Leu 7。在健康受试者中,去除CD16⁺细胞而非CD8⁺细胞可显著提高IL-2的产生。CD8⁻CD16⁺非T细胞亚群在自体和异体组合中均可抑制正常和SLE患者PBM产生IL-2。该亚群可能相当于小鼠的天然抑制细胞。这些结果表明,SLE中抑制IL-2产生的细胞是异质性的,提示它们属于不止一个谱系。